01Jan 2025
LiverPRO Tool Detects Clinically Significant Liver Fibrosis Effectively

LiverPRO Tool Detects Clinically Significant Liver Fibrosis Effectively

LiverPRO is a software tool designed to detect clinically significant liver fibrosis in primary care. It uses blood tests to predict elevated liver stiffness and liver-related events. In a study across six cohorts, LiverPRO demonstrated high accuracy for identifying fibrosis (AUC 0.86) and excellent performance in predicting liver-related events (C-statistic 0.80). It outperformed other tools like FIB-4 and LiverRisk, achieving high rule-out sensitivity (98%) and rule-in specificity (95%). LiverPRO received European CE approval in 2024.

  • #gastroenterology

Like

Save

Share